top of page
Search
INTRODUCING VEINTECH
VeinTech is working to improve first pass cannulation success rates in obese patients and ultimately in all patients with difficult venous access. What drew you to the problem you are working to solve in Biodesign? First hand experience with the frustrations of repeated cannulation attempts in patients with difficult venous access - Katherine A Prior experience solving vascular problems using biomedical engineering and growing up in a developing country where I’ve witness
Sep 1, 20194 min read
INTRODUCING SVELM INNOVATA
SVELM Innovata is working to prevent the development of Stage 1 pressure ulcers in high risk hospitalised patients What drew you to the problem you are working to solve in Biodesign? Ed: The lack of effective solutions for the problem are inadequate and that a better solution is feasible and could benefit a large number of people. Lennon: PUs prevention is not a new problem to be identified in high risk patients. I was intrigued by the Biodesign design thinking process an
Sep 1, 20193 min read
INTRODUCING MOONSHOT
Team Moonshot is working to reduce the urethral tissue damage caused by intermittent catheterisation What drew you to the problem you are working to solve in Biodesign? Joey: We appreciated a problem with a proven clinical need and a large affected population. It highlighted a strong value-add we could bring if we tackled the issue. Sarah: We felt there was a strong clinical need and that we could really make a difference to patients’ quality of life. Maddy: The current
Sep 1, 20194 min read
INTRODUCING TT MEDICAL
Team TT is working to improve respiratory functions in intubated ICU patients to reduce their hospitalised time. What drew you to the problem you are working to solve in Biodesign? As a team we wanted to solve a problem that has tangible benefits to patient outcomes, the opportunity in ICU to save downstream costs allows us to focus on patient care whilst creating value for multiple stakeholders - Chris What have you learned from the Biodesign process? Learning to work to
Sep 1, 20192 min read
MEET A TEAM OF ‘ENGIPRENEURS’ TAKING MEDICAL INNOVATIONS FROM IDEA TO MARKET
Can innovation be taught? Dr Matt Oldakowski, an entrepreneur, researcher at Curtin University and co-director of Perth Biodesign, runs an intensive six-month program that teams engineers with researchers, business professionals and clinicians. He answers the question in the affirmative. Before heading the program, Oldakowski and course co-director Intan Oldakowska spent five months in Stanford University’s renowned Biodesign Global Faculty in Training program, learning the B
Mar 14, 20192 min read
EMOTIONGAIT, WEARABLE TECH FOR THE INFORMED SUPPORT OF LOWER LIMB AMPUTEES, WINS
Medical device start-up JR-TeCH, creators of eMotionGait, a wearable technology for prostheses, has taken first prize at the 2018 Perth Biodesign Pitch Night, presented by Accelerating Australia. For above knee amputees, prescribing a suitable prosthetic is a difficult process and it can be even more difficult for the wearer to determine that their prosthesis is the cause of discomfort, instability, and a high falls-risk. This leads to 11-22% of patients abandoning their pros
Nov 6, 20183 min read
ROBERT HOWARD NEXT STEP AWARD GOES TO EARBUDDY
In late 2017, Dr Matthew Oldakowski was sponsored by Accelerating Australia and St John of God Healthcare to attend the Global Faculty in Training course at Stanford Biodesign. Matt and his team at Stanford were awarded the Robert Howard Next Step Award for their device, EarBuddy. Matt Oldakowski is a bioengineering postdoc at Curtin University and medtech entrepreneur who recently joined the team at Accelerating Australia as co-course director of the 2018 Perth Biodesign co
Jul 10, 20182 min read
LAUNCH OF ADELAIDE BIODESIGN
It's been an exciting week for medtech innovation in Adelaide with the launch of the Bridgetech program , the Ausmedtech conference and now the inaugural Adelaide biodesign course launched on Thursday 3rd May featuring special guest speaker, Dr Leanna Read, Chief Scientist for South Australia! The Perth Biodesign course has now been running for two years with great success, having now trained 53 clinicians, engineers, business professionals and researchers in the process of
May 8, 20182 min read
2017 ALUMNI SHARE THEIR EXPERIENCE OF THE PERTH BIODESIGN COURSE
The 2018 Perth Biodesign course was officially launched on Wednesday 28th March, with an event at the Centre for Entrepreneurial Research and Innovation featuring talks from 2017 SPARK Co-Lab Design Course alumni as well as world leading burns specialist and medtech entrepreneur, Dr Fiona Wood. As part of the launch event, several participants of the 2017 course (then called SPARK Co-Lab Design) spoke on their experiences and what they learned from taking part. Martina Maria
Apr 5, 20183 min read
PERTH BIODESIGN LAUNCH 2018 WITH GUEST SPEAKER, DR FIONA WOOD
The 2018 Perth Biodesign course was officially launched on Wednesday 28th March, with an event at the Centre for Entrepreneurial Research and Innovation featuring talks from 2017 SPARK Co-Lab Design Course alumni as well as world leading burns specialist and medtech entrepreneur, Dr Fiona Wood. Perth Biodesign is the new name for the course that has previously been run as the SPARK Co-Lab Design Course, and will run as a partnership between Accelerating Australia and SPARK C
Apr 1, 20182 min read
PUTTING HUMANS AT THE CENTRE OF HEALTHCARE INNOVATION
The Perth Biodesign and Adelaide Biodesign courses are based heavily on something called “Design thinking”, a way of innovating based on the ability to identify, and empathise with, a client or patient’s needs. This way of thinking leads to solutions that are both more impactful and commercially viable. The following article first appeared in the Harvard Business Review here and was written by Yasser Bhatti, Jacqueline del Castillo, Kristian Olson and Ara Darzi. The healthca
Mar 5, 20186 min read
NIMO WINS INNOVATION CENTRAL AWARD AT WEST TECH FEST
SPARK Co-Lab Design team, NIMo, have been on the innovation fast track this year with their wearable device for the self-management of...
Dec 10, 20173 min read
NIMO, WEARABLE TECH FOR MANAGEMENT OF CHRONIC DISEASE, WINS SPARK CO-LAB DESIGN COURSE PITCH NIGHT
Medical device start-up NIMo (Non-Invasive Monitoring), creators of a wearable technology solution for the non-invasive self-management of chronic disease, has taken first prize at the SPARK Co-Lab 2017 Design Course Pitch Night, presented by Accelerating Australia. With their focus on a biomarker-based solution to bring relief to sufferers of chronic illness such as inflammatory bowel disease, NIMo was one of six teams who presented at SPARK Co-Lab’s second annual Pitch Nigh
Nov 10, 20173 min read
bottom of page